Azzopardi, Laura <br/><br/>
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  Jul 2014 
 - 795-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-330X 
<br/><br/><label>Standard No.: </label>10.1136/jnnp-2013-307042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Alemtuzumab<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Autoimmune Diseases--blood<br/>Autoimmunity--drug effects<br/>Biomarkers--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Interleukins--blood<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Predictive Value of Tests<br/>Young Adult<br/>Interleukin-21